Skip to main content
logo
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
186.95
-1.32 (-0.70%)
At close: Apr 2, 2026, 4:00 PM EDT
187.25
+0.30 (0.16%)
After-hours: Apr 2, 2026, 4:53 PM EDT

Jazz Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Cash & Equivalents
1,3922,413
Short-Term Investments
1,050580
Cash & Short-Term Investments
2,4422,993
Cash Growth
-18.41%-
Accounts Receivable
830.75716.77
Inventory
416.96480.45
Other Current Assets
476.44438.95
Total Current Assets
4,1664,629
Net Property, Plant & Equipment
258.74227
Other Intangible Assets
4,4304,756
Goodwill
1,8291,716
Other Long-Term Assets
975.71684.22
Total Assets
11,65912,012
Accounts Payable
122.0677.87
Accrued Expenses
1,034910.95
Current Portion of Long-Term Debt
1,03031
Other Current Liabilities
56.3918.76
Total Current Liabilities
2,2431,039
Long-Term Debt
4,3286,078
Long-Term Leases
50.8938.94
Other Long-Term Liabilities
718.99763.35
Total Long-Term Liabilities
5,0986,880
Total Liabilities
7,3417,919
Common Stock
0.530.53
Additional Paid-in Capital
4,2403,914
Accumulated Other Comprehensive Income
-568.6-947.67
Retained Earnings
646.181,127
Shareholders' Equity
4,3194,094
Total Liabilities & Equity
11,65912,012
Total Debt
5,4096,148
Net Cash (Debt)
-2,967-3,155
Net Cash Per Share
-48.66-47.79
Book Value
4,3194,094
Book Value Per Share
70.8262.02
Tangible Book Value
-1,940-2,378
Tangible Book Value Per Share
-31.82-36.03
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q